Comparison of referring and final pathology for patients with T-cell lymphoma in the National Comprehensive Cancer Network Academic Article uri icon

Overview

MeSH Major

  • Biomarkers, Tumor
  • Lymphoma, T-Cell
  • Receptor Protein-Tyrosine Kinases
  • Referral and Consultation
  • Secondary Care

abstract

  • In a large cohort of patients with TCL who were referred to National Comprehensive Cancer Network centers, the likelihood of a concordant final diagnosis at a referring institution was low. As current and future therapies target TCL subsets, these data suggest that patients with suspected TCLs would benefit from evaluation by an expert hematopathologist.

publication date

  • July 2014

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC4130379

Digital Object Identifier (DOI)

  • 10.1002/cncr.28676

PubMed ID

  • 24706502

Additional Document Info

start page

  • 1993

end page

  • 9

volume

  • 120

number

  • 13